{"schemaVersion":"peptidescanner-evidence-bundle/v1","canonicalUrl":"https://peptidescanner.com/evidence/v1/peptides/mk-677.json","manifestUrl":"https://peptidescanner.com/evidence/v1/manifest.json","peptide":{"slug":"mk-677","name":"MK-677","url":"https://peptidescanner.com/peptides/mk-677/"},"addressing":"objects is keyed by objectPathId. A URL fragment #<objectPathId> on this file names one evidence object. Every version of a record is placed in the bundle of the record's current first peptide.","objectCount":6,"objects":{"clinicaltrials-gov-nct00395291-mk-677-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct00395291-mk-677:v1","objectPathId":"clinicaltrials-gov-nct00395291-mk-677-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00395291-mk-677/","json":"https://peptidescanner.com/evidence/v1/peptides/mk-677.json#clinicaltrials-gov-nct00395291-mk-677-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/mk-677.md#clinicaltrials-gov-nct00395291-mk-677-v1"},"story":{"slug":"clinicaltrials-gov-nct00395291-mk-677","version":1,"domain":"Clinical trials","dateInSource":"2017-02-20","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["mk-677"],"peptides":[{"slug":"mk-677","url":"https://peptidescanner.com/peptides/mk-677/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT00395291","sourceIds":["ctg-observation-nct00395291-2017-02-20-7eddc98e3167"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT00395291 at 2026-11-16T17:28:23.215Z. Its registry update date was 2017-02-20, and PeptideScanner's reviewed identity mapping was mk-677.","sourceIds":["ctg-observation-nct00395291-2017-02-20-7eddc98e3167"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT00395291 at 2026-11-16T17:28:23.215Z. Its registry update date was 2017-02-20, and PeptideScanner's reviewed identity mapping was mk-677.","sourceIds":["ctg-observation-nct00395291-2017-02-20-7eddc98e3167"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct00395291-2017-02-20-7eddc98e3167"]}],"sources":[{"id":"ctg-observation-nct00395291-2017-02-20-7eddc98e3167","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT00395291 · retained source version 2017-02-20:7eddc98e31675d85380fcc95ab40afc3ee2831e37a2fc64dad3ee3069547e5e9","url":"https://clinicaltrials.gov/study/NCT00395291"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"886a5cffeaf002134ee422b7cf367a03a504801551c6cd7c591ddf65d8cfe78e","tierARecordSha256":"4ac2ecc1d90b4a851ed55d504ee4d9a79c1b74b2563b3fce9248f757fc07da16"},"integrity":{"algorithm":"sha256","contentSha256":"5430a35eec591b530e8453a25e6edc3d86eb840f032fad15ce8e0ef2763f57cf"}},"clinicaltrials-gov-nct05364684-mk-677-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct05364684-mk-677:v1","objectPathId":"clinicaltrials-gov-nct05364684-mk-677-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct05364684-mk-677/","json":"https://peptidescanner.com/evidence/v1/peptides/mk-677.json#clinicaltrials-gov-nct05364684-mk-677-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/mk-677.md#clinicaltrials-gov-nct05364684-mk-677-v1"},"story":{"slug":"clinicaltrials-gov-nct05364684-mk-677","version":1,"domain":"Clinical trials","dateInSource":"2026-01-06","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["mk-677"],"peptides":[{"slug":"mk-677","url":"https://peptidescanner.com/peptides/mk-677/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT05364684","sourceIds":["ctg-observation-nct05364684-2026-01-06-6a1c03e1905a"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT05364684 at 2026-11-16T17:28:23.215Z. Its registry update date was 2026-01-06, and PeptideScanner's reviewed identity mapping was mk-677.","sourceIds":["ctg-observation-nct05364684-2026-01-06-6a1c03e1905a"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT05364684 at 2026-11-16T17:28:23.215Z. Its registry update date was 2026-01-06, and PeptideScanner's reviewed identity mapping was mk-677.","sourceIds":["ctg-observation-nct05364684-2026-01-06-6a1c03e1905a"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct05364684-2026-01-06-6a1c03e1905a"]}],"sources":[{"id":"ctg-observation-nct05364684-2026-01-06-6a1c03e1905a","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT05364684 · retained source version 2026-01-06:6a1c03e1905a489d737d77514f8dfbd8449021b6781afdbd2864a9b5a02a411c","url":"https://clinicaltrials.gov/study/NCT05364684"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"ce558fce87abb26505c21c12ba1f227214789c570c2beb2b28f6159b1dc5a1ea","tierARecordSha256":"c4f67528af6152c9b8f4f709203d389c5bd85ba82d8edddcc5b7521115df798a"},"integrity":{"algorithm":"sha256","contentSha256":"65dd72e3ba14756ba87237b2fadd08c480353c4f76b822c335a9f4637fbe4374"}},"pubmed-pmid-31964466-mk-677-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-31964466-mk-677:v1","objectPathId":"pubmed-pmid-31964466-mk-677-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-31964466-mk-677/","json":"https://peptidescanner.com/evidence/v1/peptides/mk-677.json#pubmed-pmid-31964466-mk-677-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/mk-677.md#pubmed-pmid-31964466-mk-677-v1"},"story":{"slug":"pubmed-pmid-31964466-mk-677","version":1,"domain":"Literature metadata","dateInSource":"2020-11-16","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["mk-677"],"peptides":[{"slug":"mk-677","url":"https://peptidescanner.com/peptides/mk-677/"}]},"claims":[{"id":"headline","text":"Antiviral activity of sertindole, raloxifene and ibutamoren against transcription and replication-competent Ebola virus-like particles.","sourceIds":["pubmed-observation-pmid-31964466-2020-11-16-b6841e2283ef"]},{"id":"summary","text":"PubMed lists PMID 31964466 in BMB reports as Journal Article, with publication-date metadata of 2020-03 (month precision). PeptideScanner associated the retained record with the identity slug mk-677. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-31964466-2020-11-16-b6841e2283ef"]},{"id":"paragraph-1","text":"PubMed lists PMID 31964466 in BMB reports as Journal Article, with publication-date metadata of 2020-03 (month precision). PeptideScanner associated the retained record with the identity slug mk-677. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-31964466-2020-11-16-b6841e2283ef"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-31964466-2020-11-16-b6841e2283ef"]}],"sources":[{"id":"pubmed-observation-pmid-31964466-2020-11-16-b6841e2283ef","name":"PubMed","sourceClass":"A","title":"Antiviral activity of sertindole, raloxifene and ibutamoren against transcription and replication-competent Ebola virus-like particles. · retained source version 1:2020-11-16:current:b6841e2283efc507f2af7da1e32e82018c68b93d0aef64af4db30c20e4fbfd00","url":"https://pubmed.ncbi.nlm.nih.gov/31964466/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"e425eee4fc09c462642d4f3a330a8c681306d260e020775418b57a404643bbfc","tierARecordSha256":"18ada7555d62f13f46d8d767d00bb27d056d310eaa755a9eb074e382c92a535d"},"integrity":{"algorithm":"sha256","contentSha256":"afd25a669f67e4a3ac42d283f6130672937fc0c8ec4f12d3b2db45943acf8feb"}},"pubmed-pmid-34542924-mk-677-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-34542924-mk-677:v1","objectPathId":"pubmed-pmid-34542924-mk-677-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-34542924-mk-677/","json":"https://peptidescanner.com/evidence/v1/peptides/mk-677.json#pubmed-pmid-34542924-mk-677-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/mk-677.md#pubmed-pmid-34542924-mk-677-v1"},"story":{"slug":"pubmed-pmid-34542924-mk-677","version":1,"domain":"Literature metadata","dateInSource":"2022-01-31","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["mk-677"],"peptides":[{"slug":"mk-677","url":"https://peptidescanner.com/peptides/mk-677/"}]},"claims":[{"id":"headline","text":"Characterization of equine liver microsome-generated metabolites of growth hormone secretagogue small molecule ibutamoren.","sourceIds":["pubmed-observation-pmid-34542924-2022-01-31-f12b83f64da5"]},{"id":"summary","text":"PubMed lists PMID 34542924 in Rapid communications in mass spectrometry : RCM as Journal Article, with publication-date metadata of 2021-12-15 (day precision). PeptideScanner associated the retained record with the identity slug mk-677. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-34542924-2022-01-31-f12b83f64da5"]},{"id":"paragraph-1","text":"PubMed lists PMID 34542924 in Rapid communications in mass spectrometry : RCM as Journal Article, with publication-date metadata of 2021-12-15 (day precision). PeptideScanner associated the retained record with the identity slug mk-677. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-34542924-2022-01-31-f12b83f64da5"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-34542924-2022-01-31-f12b83f64da5"]}],"sources":[{"id":"pubmed-observation-pmid-34542924-2022-01-31-f12b83f64da5","name":"PubMed","sourceClass":"A","title":"Characterization of equine liver microsome-generated metabolites of growth hormone secretagogue small molecule ibutamoren. · retained source version 1:2022-01-31:current:f12b83f64da5e2a95a794ac6ceb51beb07308d2bc9c2a6c8615cfae800e9ff68","url":"https://pubmed.ncbi.nlm.nih.gov/34542924/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"70f1d3cfc08f1a5cb87a4d6e7903b184ff15cbd0e0b091db0b437429820d455f","tierARecordSha256":"9898974fbf89929344d0b85134e614fb1fc6e750fcd0d08a417b58fc87c060c5"},"integrity":{"algorithm":"sha256","contentSha256":"50d3190eb81f2f4d9e398686c40467ae9ed415808e6bda7403cefeefd05eea20"}},"pubmed-pmid-34737341-mk-677-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-34737341-mk-677:v1","objectPathId":"pubmed-pmid-34737341-mk-677-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-34737341-mk-677/","json":"https://peptidescanner.com/evidence/v1/peptides/mk-677.json#pubmed-pmid-34737341-mk-677-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/mk-677.md#pubmed-pmid-34737341-mk-677-v1"},"story":{"slug":"pubmed-pmid-34737341-mk-677","version":1,"domain":"Literature metadata","dateInSource":"2022-10-20","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["mk-677"],"peptides":[{"slug":"mk-677","url":"https://peptidescanner.com/peptides/mk-677/"}]},"claims":[{"id":"headline","text":"Structural basis of human ghrelin receptor signaling by ghrelin and the synthetic agonist ibutamoren.","sourceIds":["pubmed-observation-pmid-34737341-2022-10-20-266ec2e956f6"]},{"id":"summary","text":"PubMed lists PMID 34737341 in Nature communications as Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, with publication-date metadata of 2021-11-04 (day precision). PeptideScanner associated the retained record with the identity slug mk-677. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-34737341-2022-10-20-266ec2e956f6"]},{"id":"paragraph-1","text":"PubMed lists PMID 34737341 in Nature communications as Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, with publication-date metadata of 2021-11-04 (day precision). PeptideScanner associated the retained record with the identity slug mk-677. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-34737341-2022-10-20-266ec2e956f6"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-34737341-2022-10-20-266ec2e956f6"]}],"sources":[{"id":"pubmed-observation-pmid-34737341-2022-10-20-266ec2e956f6","name":"PubMed","sourceClass":"A","title":"Structural basis of human ghrelin receptor signaling by ghrelin and the synthetic agonist ibutamoren. · retained source version 1:2022-10-20:current:266ec2e956f602a3cf5441e73d0b374daf715a5931522f50dd222d825d7a8193","url":"https://pubmed.ncbi.nlm.nih.gov/34737341/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"89a9128d34c753f34eb0a1dc1811ad01e374600f2dd3585f85464c764f69ba5e","tierARecordSha256":"27e6a540996e12f1652833ceb3c71353c609d516fdf488c4bb073d57ea5f29cc"},"integrity":{"algorithm":"sha256","contentSha256":"2abe96751bf94604787d471f3c16be564a677cd5c0d0121ffc1fdee831cb1658"}},"pubmed-pmid-36303408-mk-677-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-36303408-mk-677:v1","objectPathId":"pubmed-pmid-36303408-mk-677-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-36303408-mk-677/","json":"https://peptidescanner.com/evidence/v1/peptides/mk-677.json#pubmed-pmid-36303408-mk-677-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/mk-677.md#pubmed-pmid-36303408-mk-677-v1"},"story":{"slug":"pubmed-pmid-36303408-mk-677","version":1,"domain":"Literature metadata","dateInSource":"2026-01-27","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["mk-677"],"peptides":[{"slug":"mk-677","url":"https://peptidescanner.com/peptides/mk-677/"}]},"claims":[{"id":"headline","text":"LGD-4033 and MK-677 use impacts body composition, circulating biomarkers, and skeletal muscle androgenic hormone and receptor content: A case report.","sourceIds":["pubmed-observation-pmid-36303408-2026-01-27-4bdf8b698c40"]},{"id":"summary","text":"PubMed lists PMID 36303408 in Experimental physiology as Case Reports, Research Support, Non-U.S. Gov't, Journal Article, with publication-date metadata of 2022-11-16 (day precision). PeptideScanner associated the retained record with the identity slug mk-677. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-36303408-2026-01-27-4bdf8b698c40"]},{"id":"paragraph-1","text":"PubMed lists PMID 36303408 in Experimental physiology as Case Reports, Research Support, Non-U.S. Gov't, Journal Article, with publication-date metadata of 2022-11-16 (day precision). PeptideScanner associated the retained record with the identity slug mk-677. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-36303408-2026-01-27-4bdf8b698c40"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-36303408-2026-01-27-4bdf8b698c40"]}],"sources":[{"id":"pubmed-observation-pmid-36303408-2026-01-27-4bdf8b698c40","name":"PubMed","sourceClass":"A","title":"LGD-4033 and MK-677 use impacts body composition, circulating biomarkers, and skeletal muscle androgenic hormone and receptor content: A case report. · retained source version 1:2026-01-27:current:4bdf8b698c40396ed3ccb1d4e186d7e161a0102c4dc9e10a4e3a4e39377e3861","url":"https://pubmed.ncbi.nlm.nih.gov/36303408/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"c7fded96b7b28556d1e5dea8a7233d583490de897d6d9df86cfa3ca97c647569","tierARecordSha256":"bfd7c6501f85cd89207319122dae1787988657315dfb696c7e099d95ae5d5857"},"integrity":{"algorithm":"sha256","contentSha256":"0066b10306820b3ac745df38816e999727dca69a9076f5e045edbf2bc15f6779"}}}}
